Corporate Banner
Satellite Banner
Scientific Community
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012

2nd Reverse Phase Protein Array Global Workshop

12 Nov 2012 - 13 Nov 2012 - Edinburgh, Scotland, UK

Bookmark and Share

Key Workstreams;

  • Challenges, needs, advantages and disadvantages associated with printing and detection
  • Image acquisition, data processing and normalization
  • Validating and sharing of Antibody data
  • Alignment with "Proteomics Standard Initiative" (PSI) at HUPO
  • New technologies showcase
  • Pharmaceutical Discovery applications
  • RPPA in management and analysis of clinical samples
  • How to use RPA Data in the Clinic (i.e. PD Marker, Prognostic Marker and Predictive Marker):
  • Launch : Global RPPA Society

The evolution of Reverse Phase Protein Array (RPPA ) technologies has facilitated the application of high-throughput functional proteomics in patient samples and preclinical drug screening with improved sensitivity and quantification to support the identification and analysis of post-translational biomarkers and pathway networks.

Advancing RPPA technology into mainstream basic research, drug discovery and clinical diagnostics applications will require improved consistency in methods and an expanded portfolio of validated antibody reagents and procedures that can be shared across the community.

Hosted by the University of Edinburgh, the second Reverse Phase Protein Array Global Workshop will bring together scientists from both academia and industry to discuss the latest technical advances and standards for generating and analysing results using Reverse Phase Protein Arrays.

The 2012 workshop shall also be used to launch a global RPPA society to support communication, data-sharing and ambitions of the RPPA community.

Further information
Scientific News
New Gene Therapy for Vision Loss From a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Five New Genetic Variants Linked to Brain Cancer Identified
The biggest ever study of DNA from people with glioma – the most common form of brain cancer – has discovered five new genetic variants associated with the disease.
Predictive Model for Breast Cancer Progression
Biomedical engineers have demonstrated a proof-of-principle technique that could give women and their oncologists more personalized information to help them choose options for treating breast cancer.
Fatty Liver Disease and Scarring Have Strong Genetic Component
Researchers say that hepatic fibrosis, which involves scarring of the liver that can result in dysfunction and, in severe cases, cirrhosis and cancer, may be as much a consequence of genetics as environmental factors.
Specific Variations in RNA Splicing Linked to Breast Cancer
Researchers have identified cellular changes that may play a role in converting normal breast cells into tumors. Targeting these changes could potentially lead to therapies for some forms of breast cancer.
Finding Links and Missing Genes
A catalogue of large-scale genetic changes around the world.
Scientists Test New Gene Therapy for Vision Loss from a Mitochondrial Disease
NIH-funded study shows success in targeting mitochondrial DNA in mice.
Gene Expression: A Snapshot of Stem Cell Development
New genes found that regulate development of stem cells.
Assessing Cancer Patient Survival and Drug Sensitivity
RNA editing events another way to investigate biomarkers and therapy targets.
A Natural History of Neurons
Diverse mutations reveal lineage of brain cells.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,600+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,800+ scientific videos